THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Biogen Idec to rearrange drug lineup

New CEO plans to sharpen focus in selected areas

By Robert Weisman
Globe Staff / October 6, 2010

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

CAMBRIDGE — Scientists at Biogen Idec Inc.’s warren of research labs in Kendall Square are working to discover treatments for diseases ranging from lupus to multiple sclerosis. (Full article: 1107 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass